Session

Urological infections

Poster Session 13

  • Location:
    Room London (Hall B2, level 0)
  • Chairs:
     F. Bruyere, Tours (FR)
     T. Cai, Trento (IT)
  • Aims and objectives of this session

    Infectious urological diseases overview of current clinical and research state-of-the-art.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
148
Four-year prospective study evaluating healthcare-associated infections (HAIs) in a urology ward: Risk factors, microbiological characteristics, and temporal evolution

By: Medina Polo J., Sopeña-Sútil R., Arrébola-Pajares A., Pérez-Cadavid S., Benítez-Sala R., Lara-Isla A., Alonso-Isa M., Gil-Moradillo J., Justo-Quintas J., García-Rojo E., González-Padilla D.A., Aguilar-Gisbert L., Miranda-Utrera N., Passas-Martínez J.B., Tejido-Sánchez A.

Institutes: Hospital Universitario 12 de Octubre, Dept. of Urology, Madrid, Spain

149
Recommended initial antimicrobial therapy for emphysematous pyelonephritis: 51 cases and 14-year-experience of a tertiary referral center

By: Lu Y-C.1, Wang S-M.1, Huang C-Y.2

Institutes: 1National Taiwan University Hospital Yun-Lin Branch, Dept. of Urology, Douliou City, Taiwan, 2National Taiwan University Hospital, Dept. of Urology, Taipei, Taiwan

150
Is pre-operative urine culture sufficient to predict septic complications of percutaneous nephrolithotomy?

By: Chakroun M., Kerkeni W., Bouzouita A., Saadi A., Ayed H., Cherif M., Derouiche A., Ben Slama M.R., Chebil M.

Institutes: Charles Nicolle Hospital, Dept. of Urology, Tunis, Tunisia

151
Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases

By: Fujiwara M., Inoue M., Yokoyama M., Nakayama T., Ito M., Kijima T., Yoshida S., Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K.

Institutes: Tokyo Medical And Dental University, Dept. of Urology, Tokyo, Japan

152
Infections in patients with catheters into the upper urinary tract

By: Medina Polo J., Lara-Isla A., Pérez-Cadavid S., Arrébola-Pajares A., Benítez-Sala R., Sopeña-Sutil R., Alonso-Isa M., Justo-Quintas J., Gil-Moradillo J., González-Padilla D.A., García-Rojo E., Aguilar-Gisbert L., Miranda-Utrera N., Passas-Martínez J.B., Tejido-Sánchez A.

Institutes: Hospital Universitario 12 de Octubre, Dept. of Urology, Madrid, Spain

153
Saving lives: Reducing the risk of catheter-associated urinary tract infections

By: Clarke L.1, Taylor J.1, Rowbotham D.2, Grayson S.2, Morris F.3, Blears C.4, Hunt C.2, Murphy P.5, Simpson R.1, Kadler B.1, O’Flynn K.1, Shackley D.1

Institutes: 1Salford Royal NHS Foundation Trust, Dept. of Urology, Salford, United Kingdom, 2Salford Royal NHS Foundation Trust, Dept. of Quality Improvement, Salford, United Kingdom, 3Salford Royal NHS Foundation Trust, Nursing and Corporate Services, Salford, United Kingdom, 4Salford Royal NHS Foundation Trust, Community Bladder and Bowel Service, Salford, United Kingdom, 5Salford Royal NHS Foundation Trust, Dept. of Nursing, Salford, United Kingdom

154
Preoperative hospital stay would be risks of resistant bacteria emergence after radical cystectomy: Analysis of 11,410 cases

By: Sugihara T.1, Yasunaga H.2, Matsui H.2, Fushimi K.3, Gondo T.4, Nakagami Y.4, Horiguchi Y.4, Ohno Y.4, Namiki K.4, Ohori M.4, Nakashima J.4, Tachibana M.1, Homma Y.4

Institutes: 1Tokyo Medical University, Dept. of Urology, Tokyo, Japan, 2The University of Tokyo, Dept. Clinical Epidemiology and Health Economics, Tokyo, Japan, 3Tokyo Medical and Dental University, Dept. Health Care Informatics, Tokyo, Japan, 4The University of Tokyo, Dept. of Urology, Tokyo, Japan

155
Is targeted antibiotic prophylaxis for transrectal prostate biopsy based on rectal swab cultures still effective to prevent infective complications?

By: Nasu Y.1, Murata T.1, Kosaka N.2

Institutes: 1Okayama Rosai Hospital, Dept. of Urology, Okayama, Japan, 2Okayama Rosai Hospital, Dept. of Clinical Laboratory, Okayama, Japan

156
Increasing incidence of blood-culture positive infectious complications following transrectal prostate biopsies

By: Lahdensuo M.K.1, Rannikko A.1, Anttila V-J.2, Erickson A.3, Pätäri-Sampo A.4, Rautio M.4, Santti H.1, Tarkka E.4, Vaara M.4, Huotari K.2

Institutes: 1Helsinki University Hospital, Dept. of Urology, Helsinki, Finland, 2Helsinki University Hospital, Dept. of Infectious Diseases, Helsinki, Finland, 3FIMM, Institute for Molecular Medicine, Helsinki, Finland, 4Helsinki University Hospital, Dept. of Clinical Microbiology, Helsinki, Finland

157
Non-antibiotic strategies for reducing infective complications in men undergoing prostate biopsy: A systematic review and meta-analysis

By: Pilatz A.1, Pradere B.2, Yuan Y.3, Adewuyi T.4, Cek M.5, Pickard R.6, Bruyere F.2

Institutes: 1Justus Liebig University of Giessen, Dept. of Urology, Pediatric Urology and Andrology, Gießen, Germany, 2University Hospital of Tours, Dept. of Urology, Tours, France, 3McMaster University, Faculty of Health Sciences, Hamilton, Canada, 4University of Aberdeen, Dept. of Academic Urology, Aberdeen, United Kingdom, 5Trakya University, Dept of Urology, Edirne, Turkey, 6Newcastle University, Dept. of of Cellular Medicine, Edirne, United Kingdom

158
Targeted antibiotic prophylaxis reduces infectious complications following transrectal ultrasound guided prostate biopsy: Data from a developing country

By: Singh P.1, Kumar A.1, Kapil A.2, Dogra P.N.1

Institutes: 1All India Institute of Medical Sciences, Dept. of Urology, New Delhi, India, 2All India Institute of Medical Sciences, Dept. of Microbiology, New Delhi, India

159
Screening for fluoroquinolone resistant E coli in rectal flora prior to transrectal ultrasound guided prostate biopsy reduces the risk of post biopsy sepsis

By: Holmes M.A.1, Lyons M.1, Leyland J.1, Devcich G.1, Davies A.1, Smit L.1, Mansell C.2

Institutes: 1Waikato Hospital, Dept. of Urology, Hamilton, New Zealand, 2Waikato Hospital, Dept. of Microbiology, Hamilton, New Zealand

160
Accuracy of dipstick urine analysis and urine flow cytometry to predict bacteriuria prior to GreenLight laservaporisation of the prostate

By: Bonkat G.1, Halla A.1, Seifert H.1, Müller G.1, Egli A.2, Regeniter A.3, Gasser T.1, Bachmann A.1, Rieken M.1

Institutes: 1University Hospital Basel, Dept. of Urology, Basel, Switzerland, 2University Hospital Basel, Dept. of Medical Microbiology, Basel, Switzerland, 3University Hospital Basel, Dept. of Laboratory Medicine, Basel, Switzerland

161
Evaluation of risk factors for chronic bacterial prostatitis

By: Lee G.1, Kim C.S.2, Seo Y.1

Institutes: 1Dankook University Medical College, Dept. of Urology, Cheonan, ChungNam, South Korea, 2Chosun University Hospital, Dept. of Urology, Gwangju, South Korea

162
Pharmacokinetics of fluoroquinolones into human epididymis

By: Sadahira T., Wada K., Araki M., Ebara S., Watanabe M., Watanabe T., Nasu Y.

Institutes: Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Dept. of Urology, Okayama, Japan